WallStSmart

Heartbeam Inc (BEAT)vsWaystar Holding Corp. Common Stock (WAY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

WAY leads profitability with a 10.2% profit margin vs 0.0%. WAY earns a higher WallStSmart Score of 51/100 (C-).

BEAT

Avoid

16

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 2.8
Piotroski: 1/9Altman Z: -44.35

WAY

Buy

51

out of 100

Grade: C-

Growth: 6.0Profit: 6.0Value: 5.7Quality: 6.0
Piotroski: 2/9Altman Z: 1.55
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BEAT.

WAYSignificantly Overvalued (-471.8%)

Margin of Safety

-471.8%

Fair Value

$4.15

Current Price

$23.54

$19.39 premium

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BEAT0 strengths · Avg: 0/10

No standout strengths identified

WAY4 strengths · Avg: 9.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Operating MarginProfitability
23.6%8/10

Strong operational efficiency at 23.6%

Revenue GrowthGrowth
24.3%8/10

Revenue surging 24.3% year-over-year

Areas to Watch

BEAT4 concerns · Avg: 3.8/10
Price/BookValuation
16.3x4/10

Trading at 16.3x book value

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$47.46M3/10

Smaller company, higher risk/reward

WAY4 concerns · Avg: 3.5/10
P/E RatioValuation
39.4x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : BEAT

BEAT has a balanced fundamental profile.

Bull Case : WAY

The strongest argument for WAY centers on Price/Book, Debt/Equity, Operating Margin. Revenue growth of 24.3% demonstrates continued momentum.

Bear Case : BEAT

The primary concerns for BEAT are Price/Book, Revenue Growth, EPS Growth.

Bear Case : WAY

The primary concerns for WAY are P/E Ratio, Altman Z-Score, Return on Equity.

Key Dynamics to Monitor

BEAT profiles as a value stock while WAY is a growth play — different risk/reward profiles.

WAY is growing revenue faster at 24.3% — sustainability is the question.

WAY generates stronger free cash flow (57M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WAY scores higher overall (51/100 vs 16/100) and 24.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Heartbeam Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.

Visit Website →

Waystar Holding Corp. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Waystar Holding Corp. The company is headquartered in Lehi, Utah.

Visit Website →

Want to dig deeper into these stocks?